These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 17913209)
1. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State. Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209 [TBL] [Abstract][Full Text] [Related]
2. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India. Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792 [TBL] [Abstract][Full Text] [Related]
3. Study on the factors affecting the MDA programme in Kerala state. Showkath Ali MK; Rajendran R; Regu K; Mohanan MK; Dhariwal AC; Lal S J Commun Dis; 2007 Mar; 39(1):51-6. PubMed ID: 18338717 [TBL] [Abstract][Full Text] [Related]
4. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India. Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007 [TBL] [Abstract][Full Text] [Related]
5. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Babu BV; Kar SK Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460 [TBL] [Abstract][Full Text] [Related]
6. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine. Ramaiah KD; Vanamail P; Das PK Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256 [TBL] [Abstract][Full Text] [Related]
7. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis. Ramaiah KD; Das PK; Vanamail P; Pani SP Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389 [TBL] [Abstract][Full Text] [Related]
8. A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India. Kumar A; Sachan P; Bajpei A; Singh T J Commun Dis; 2013; 45(1-2):33-40. PubMed ID: 25141552 [TBL] [Abstract][Full Text] [Related]
9. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. Lahariya C; Mishra A J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659 [TBL] [Abstract][Full Text] [Related]
10. Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF). Pani SP; Das LK; Vanamail P J Commun Dis; 2005 Mar; 37(1):12-7. PubMed ID: 16637395 [TBL] [Abstract][Full Text] [Related]
11. Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State. Showkath AM; Regu K; Rajendran R; Mohanan MK; Ganesh B J Commun Dis; 2008 Mar; 40(1):37-40. PubMed ID: 19127667 [TBL] [Abstract][Full Text] [Related]
12. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Ramaiah KD; Das PK; Vanamail P; Pani SP Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843 [TBL] [Abstract][Full Text] [Related]
13. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India. Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322 [No Abstract] [Full Text] [Related]
14. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India. Ranganath BG J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778 [No Abstract] [Full Text] [Related]
15. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India. Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435 [TBL] [Abstract][Full Text] [Related]
16. A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India. Babu BV Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):44-5. PubMed ID: 15906640 [TBL] [Abstract][Full Text] [Related]
17. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India. Ramaiah KD; Vanamail P; Yuvaraj J; Das PK Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901 [TBL] [Abstract][Full Text] [Related]
18. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance. Babu BV; Mishra S Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1207-13. PubMed ID: 18632125 [TBL] [Abstract][Full Text] [Related]
19. Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka. Gunawardena S; Sri Ranganathan S; Fernandopulle R Trop Med Int Health; 2008 Sep; 13(9):1153-8. PubMed ID: 18631319 [TBL] [Abstract][Full Text] [Related]
20. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations. Sunish IP; Munirathinam A; Kalimuthu M; Ashok Kumar V; Tyagi BK J Trop Pediatr; 2014 Jun; 60(3):245-8. PubMed ID: 24343822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]